CANINE DIABETES MELLITUS: A COMPREHENSIVE REVIEW OF PATHOGENESIS, DIAGNOSIS AND MANAGEMENT STRATEGIES

S.P. Abhijith; V.S. Lathamani; M.A. Kshama

doi:10.56093/ijvasr.v54i5.172388

Authors

S.P. Abhijith M.V.Sc. Scholar, Department of Veterinary Medicine, Veterinary College, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru - 560 024
V.S. Lathamani Assistant Professor, Department of Veterinary Medicine, Veterinary College, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru - 560 024
M.A. Kshama Professor and Head, Department of Veterinary Medicine, Veterinary College, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru - 560 024

https://doi.org/10.56093/ijvasr.v54i5.172388

Keywords:

pancreatitis, hyperglycemia, dietary control, insulin deficiency, insulin therapy

Abstract

Canine diabetes mellitus is a common endocrine disorder in dogs, closely resembling type 1 diabetes in humans, and is marked by chronic hyperglycemia from pancreatic β-cell destruction or dysfunction, causing insulin deficiency. Contributing factors include genetic predisposition, hormonal imbalances, pancreatitis, and certain drugs. It occurs most often in older, female, and breed-susceptible dogs. Typical signs include polyuria, polydipsia, weight loss, and bilateral cataracts, with diagnosis based on persistent fasting hyperglycemia and glucosuria. Management requires lifelong insulin therapy, dietary control, and monitoring through tools such as blood glucose curves and Fructosamine testing. Complications like diabetic ketoacidosis, cataracts, and urinary tract infections are frequent and need timely intervention. Advances in continuous glucose monitoring, immunotherapy, and molecular diagnostics have improved outcomes. With proper therapy and owner compliance, affected dogs can maintain a good quality of life. Research is focusing on early detection, genetic screening, and innovative treatments like stem cell therapy and pancreatic islet regeneration, ensuring continued progress in controlling this complex disease.

Downloads

Download data is not yet available.

References

Adams, V.J. and O’Neill, D.G. (2004). The use of oral hypoglycaemic agents in canine diabetes mellitus. The Veterinary Record, 154 (25), 819–823.

Aragona, F., Bonanno, E., Gatti, V. and Vanzini, F. (2020). Stem cell therapy for diabetes in dogs: A review. Veterinary Quarterly, 40 (1), 108–117.

Beam, S.L., Holmberg, A. and Komaromy, A.M. (1999). The progression of diabetic cataracts in dogs: A prospective study. Journal of the American Veterinary Medical Association, 215(1), 180–185.

Behrend, E.N. (2019). The 2018 American Animal Hospital Association Diabetes Management Guidelines for Dogs and Cats. The Veterinary Clinics of North America. Small Animal Practice, 49(5), 899–906.

Behrend, E.N., Brault, L.S. and the American Animal Hospital Association. (2018). The AAHA Diabetes Management Guidelines for Dogs and Cats. Journal of the American Animal Hospital Association, 54(5), 231–247.

Brown, J. and Reusch, C.E. (2011). The use of metformin in diabetic dogs: A retrospective study. Journal of Small Animal Practice, 52 (1), 34–38.

Catchpole, B., Adams, J.P., Holder, A.L., Short, A.D. andm Ollier, W.E. (2008). Genetics of canine diabetes mellitus: Are the diabetes susceptibility genes identified in humans involved in breed predisposition to diabetes mellitus in dogs? Veterinary Journal, 179 (3), 356–363.

Catchpole, B., Kennedy, L.J., Davison, L.J. and Ollier, W.E. (2008). Canine diabetes mellitus: From phenotype to genotype. Journal of Small Animal Practice, 49 (1), 4–10.

Catchpole, B., Ristic, J.M., Fleeman, L.M. and Davison, L.J. (2005). Canine diabetes mellitus: Can old dogs teach us new tricks? Diabetologia, 48 (10), 1948–1956.

Corradini, S., Peli, A. and Reusch, C.E. (2016). Assessment of a flash glucose monitoring system (Free Style Libre) in diabetic dogs. Tierarztliche Praxis Ausgabe K, 44 (2), 108–114.

Cowie, S., O’Neill, D.G. and Smith, J.M. (2020). The use of continuous glucose monitoring systems and artificial intelligence in the management of diabetes in dogs. Journal of Veterinary Internal Medicine, 34 (4), 1681–1688.

Davidson, M.G. (2003). Ocular manifestations of endocrine disease. In K. N. Gelatt (Ed.), Veterinary ophthalmology (4th ed., pp. 1162–1177). Blackwell Publishing.

Davison, L.J., Herrtage, M.E. and Catchpole, B. (2003). Anti-islet cell antibodies in dogs with diabetes mellitus. The Veterinary Record, 153 (14), 434–436.

Davison, L.J., Herrtage, M.E. and Catchpole, B. (2005). Study of 253 dogs in the United Kingdom with diabetes mellitus. The Veterinary Record, 156 (15), 467–471.

Davison, L.J., Herrtage, M.E. and Catchpole, B. (2007). Canine diabetes mellitus: Can old dogs teach us new tricks? ResearchGate.

Davison, L.J., Herrtage, M.E. and Catchpole, B. (2008). Insulin autoantibodies and type 1 diabetes mellitus in dogs. The Veterinary Journal, 175 (1), 162–167.

Davison, L.J., Lambert, M.R. and Catchpole, B. (2011). Canine diabetes mellitus: A review of the genetic and environmental factors. The Veterinary Journal, 189 (1), 22–29.

Fall, T., Hamlin, H.H., Hedhammar, Å. and Egenvall, A. (2007). Diabetes mellitus in a population of 180,000 insured dogs: Incidence, survival, and breed distribution. Journal of Veterinary Internal Medicine, 21(6), 1193–1197.

Feldhahn, A., Eberspacher, E. and Geyer, J. (1999). Fructosamine concentrations in normal and diabetic dogs. Tierarztliche Praxis Ausgabe K, 27(4), 218–223.

Feldman, E.C. and Nelson, R.W. (2004). Canine and feline endocrinology and reproduction (3rd ed.). Saunders.

Feldman, E.C., Nelson, R.W., and Couto, C.G. (2015). Endocrine emergencies. In R. W. Nelson, C. G. Couto, & S. J. Ettinger (Eds.), Small animal internal medicine (5th ed., pp. 635–660). Mosby.

Ferlizza, E., Giacomazzi, D. and Fracassi, F. (2015). Metabolomic analysis of saliva and plasma in diabetic dogs. Veterinary Research Communications, 39(1), 69–75.

Fleeman, L.M. and Rand, J.S. (2001). Evaluation of eight-hour hyperglycaemic-glucose tolerance test in 18 diabetic dogs. Journal of Veterinary Internal Medicine, 15(2), 163–169.

Fleeman, L.M., and Rand, J.S. (2003). Monitoring and management of the diabetic dog: A survey of small animal veterinarians. Australian Veterinary Journal, 81(1-2), 48–55.

Fleeman, L.M. and Rand, J.S. (2013). Management of canine diabetes mellitus. In S.J. Ettinger and E.C. Feldman (Eds.), Textbook of veterinary internal medicine (7th ed., pp. 1779–1793). Elsevier.

Forrester, S.D., Troy, G.C. and Leman, A.D. (1990). Urinary tract infection in dogs with diabetes mellitus. Journal of the American Animal Hospital Association, 26(3), 333–339.

Fracassi, F., Corradini, S. and Gilor, C. (2017). Glucagon-like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP-4) in dogs with diabetes mellitus. Journal of Veterinary Internal Medicine, 31(3), 850–855.

Gelatt, K.N., MacKay, E.O. and Nelson, R.W. (2006). Veterinary ophthalmology (4th ed.). Blackwell Publishing.

Gilor, C., Niessen, S.J.M. and Zini, E. (2016). Technology in the diagnosis and management of diabetes in dogs and cats. Veterinary Clinics of North America: Small Animal Practice, 46(3), 433–449.

Gilor, C., Sheshtawy, A.B. and Reusch, C.E. (2011). Sodium-glucose cotransporter-2 inhibitors: A potential new class of oral hypoglycemic agents for the treatment of canine diabetes mellitus? Veterinary Research Communications, 35(6), 481–490.

Graham, P.A. (2017). Management of canine diabetes mellitus. Veterinary Clinics of North America: Small Animal Practice, 47(5), 963–982.

Graham, P.A. and Nelson, R.W. (2005). Medical management of canine diabetes mellitus. Compendium on Continuing Education for the Practicing Veterinarian, 27(12), 903–911.

Guptill, L., Glickman, L.T. and Glickman, N.W. (2003). Time trends and risk factors for diabetes mellitus in dogs. Journal of the American Animal Hospital Association, 39(3), 251–260.

Guptill, L., Glickman, L. and Glickman, N. (2003). Time trends and risk factors for diabetes mellitus in dogs: Analysis of veterinary medical database records (1970–1999). Veterinary Journal, 165(3), 240–247.

Hess, R.S., Davis, B.D. and Fischer, R.L. (2008). The utility of home monitoring of blood glucose in diabetic dogs. Journal of the American Animal Hospital Association, 44(2), 112–118.

Hess, R.S., Kass, P.H. and Van Winkle, H. (2003). The prevalence of diabetes mellitus among dogs examined at a veterinary medical teaching hospital. Journal of the American Veterinary Medical Association, 222(11), 1693–1699.

Hess, R.S., Kass, P.H., Van Winkle, H. and Smith, C.L. (2000). Canine diabetes mellitus: An analysis of clinical and laboratory findings in 75 dogs. Journal of the American Animal Hospital Association, 36(2), 149–155.

Hoenig, M. (2002). Comparative aspects of diabetes mellitus in dogs and cats. Molecular and Cellular Endocrinology, 197(1-2), 199–204.

Johnson, J. and Rand, J.S. (2008). Diet and the management of canine diabetes mellitus: A review of current research. Journal of Veterinary Internal Medicine, 22(1), 12–20.

Johnson, J. and Rand, J.S. (2016). Continuous glucose monitoring in dogs: A review of current technology and clinical applications. Veterinary Clinics of North America: Small Animal Practice, 46(3), 451–460.

Keenan, T., Nelson, R.W., Feldman, E.C. and Griffey, S.M. (2003). Treatment and outcome of 42 dogs with pituitary- dependent hyperadrenocorticism and diabetes mellitus. Journal of the American Veterinary Medical Association, 223(4), 598–603.

Kern, T.J. (2007). Small animal ophthalmology: A practitioner’s guide. Blackwell Publishing.

Kour, M., Wani, S.A., Singh, N., Rather, H.U., Saini, N.S. and Singh, P. (2020). Systemic hypertension in dogs with diabetes mellitus. Journal of Veterinary Internal Medicine, 34(3), 1184–1188.

Martinez, J., Gilor, C. and Zini, E. (2018). Flash glucose monitoring in diabetic dogs: An evaluation of accuracy and agreement. Journal of Veterinary Internal Medicine, 32(3), 1121–1127.

Mattin, M.J., O’Neill, D.G., Church, D.B., McGreevy, P.D., Thomson, P.C. and Brodbelt, D.C. (2014). An epidemiological study of diabetes mellitus in dogs attending first opinion practice in the UK. Veterinary Record, 174 (14), 349.

Mattin, M., O’Neill, D., Church, D., McGreevy, P.D., Thomson, P.C. and Brodbelt, D. (2014). An epidemiological study of diabetes mellitus in dogs attending first opinion practice in the UK. The Veterinary Record, 174 (14), 349.

Nelson, R.W. (2015). Canine diabetes mellitus. In S.J. Ettinger and E.C. Feldman (Eds.), Textbook of Veterinary Internal Medicine (7th ed., pp. 1782–1802). St. Louis: Saunders Elsevier.

Nelson, R.W. and Couto, C.G. (2014). Small animal internal medicine (5th ed.). Mosby.

Nelson, R.W. and Reusch, C.E. (2014). Classification and etiology of diabetes in dogs and cats. Journal of Endocrinology, 222 (3), T1–T9.

Nelson, R.W., Feldman, E.C. and Reusch, C.E. (2014). Diabetes mellitus. In E.C. Feldman, R.W. Nelson, and C.E. Reusch (Eds.), Canine and feline endocrinology and reproduction (4th ed., pp. 248–294). Elsevier.

Rafferty, A. and Reusch, C.E. (2022). Insulin analogues in canine diabetes mellitus: A review of the literature. Journal of Veterinary Internal Medicine, 36(2), 650–658.

Rand, J.S., Fleeman, L.M., Farrow, H.A., Appleton, D.J. and Lederer, R. (2004). Canine and feline diabetes mellitus: Nature or nurture? Journal of Nutrition, 134 (8), 2072S–2080S.

Reusch, C.E. (2002). Canine diabetes mellitus. Veterinary Clinics of North America: Small Animal Practice, 32(4), 863–882.

Short, A.D., Holder, A.L., Thomson, W. and Ollier, W.E. (2007). Analysis of canine MHC class II haplotypes and their association with breed-specific diseases. Journal of Veterinary Internal Medicine, 21(4), 748–755.

Sidhu, A.S., Saini, N., Saini, S.S. and Roy, K.S. (2019). Genetic risk factors and clinical management of canine diabetes mellitus. The Veterinary Journal, 254: 105423.

Smith, J.M. and O’Neill, D.G. (2020). Optimal insulin dosing strategies for diabetic dogs: A systematic review. The Veterinary Journal, 266: 105553.

Strage, E., Zini, E., Glaus, T. and Reusch, C.E. (2002). Relationship between serum fructosamine and fasting blood glucose in diabetic dogs. Journal of Veterinary Internal Medicine, 16(4), 433–437.

Thomson, L.E. and Fleeman, L.M. (2016). Remission of diabetes mellitus in dogs: A review of case reports. Journal of Small Animal Practice, 57(11), 603–608.

Thomson, L.E., O’Neill, D.M. and Fleeman, L.M. (2010). The effect of dietary fiber on glycemic control in diabetic dogs: A systematic review. Journal of Animal Physiology and Animal Nutrition, 94(3), 361–368.

Tvarijonaviciute, A., Ceron, J.J. and Morales, M. (2012). Serum concentrations of fructosamine and advanced glycation end products in diabetic dogs. Veterinary Journal, 191 (2), 263–267.

Wess, G., Mittermann, A. and Reusch, C. E. (2000). Blood glucose and fructosamine concentrations in dogs with stress-induced hyperglycemia. Journal of Veterinary Internal Medicine, 14(6), 578–581.

Wiedmeyer, C.E. and Riches, D.W. (2008). Insulin therapy for diabetic ketoacidosis in dogs: A review. Journal of Veterinary Internal Medicine, 22(3), 515–520.

Williams, D.L., Pickles, S.T., Aalders, S.M. and Reusch, C.E. (2006). Aldose reductase and sorbitol pathway in the dog lens: The role of aldose reductase inhibitors in preventing diabetic cataract formation. Veterinary Record, 159(15), 503–506.

Xenoulis, P.G., Suchodolski, J.S. and Steiner, J.M. (2008). Chronic pancreatitis in dogs: A review of current knowledge. Journal of Small Animal Practice, 49(1), 1–8.

Zini, E., Forcada, Y., & Reusch, C. E. (2009). Evaluation of a portable glucometer for home monitoring of blood glucose concentrations in dogs. Journal of Veterinary Internal Medicine, 23(5), 978–984.

Zini, E., Forcada, Y. and Reusch, C.E. (2010). Continuous glucose monitoring in dogs and cats. Veterinary Clinics of North America: Small Animal Practice, 40 (4), 585-599.